Form 4: National Healthcare Corp CEO Granted 18,000 Stock Options
SEC Form 4 Filing
CEO Stephen F. Flatt of National Healthcare Corp. was granted 18,000 stock options on February 24, 2025, according to a recent SEC filing.
Summary
- Stephen F. Flatt, CEO of National Healthcare Corp (NHC), was granted 18,000 stock options on February 24, 2025.
- The options have an exercise price of $90.62.
- These options were granted under the 2020 Omnibus Equity Incentive Plan and are exempt from Section 16(b) under Rule 16b-3(d).
- The options vest ratably over three years, starting February 24, 2026, and expire on February 28, 2030.
- Flatt directly owns 54,665 shares of NHC common stock.
Sentiment
Score: 6
Explanation: The document itself is neutral, simply reporting a stock option grant. The sentiment is slightly positive as it indicates continued investment in the company's leadership.
Positives
- The stock option grant aligns the CEO's interests with those of the shareholders, incentivizing him to improve the company's performance.
- The vesting schedule encourages long-term commitment from the CEO.
Industry Context
Stock option grants are a common practice in the healthcare industry to incentivize executives and align their interests with shareholders. The vesting schedule is typical for such grants.
Comparison to Industry Standards
- Stock option grants are a common form of executive compensation across the healthcare industry.
- Companies like Brookdale Senior Living and Sunrise Senior Living also utilize stock options as part of their executive compensation packages.
- The size of the grant and the vesting schedule are generally in line with industry standards for companies of similar size and market capitalization.
Stakeholder Impact
- Shareholders may view the stock option grant positively as it incentivizes the CEO to improve company performance.
- Employees may see the grant as a sign of confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 02/18/2023 | Date of previous option grant with expiration date 02/18/2027. |
| 03/08/2024 | Date of previous option grant with expiration date 03/08/2028. |
| 03/05/2025 | Date of previous option grant with expiration date 03/05/2029. |
| 02/24/2025 | Date of the stock option grant to Stephen F. Flatt. |
| 02/26/2025 | Date of the Form 4 filing. |
| 02/28/2026 | First vesting date for the granted stock options (1/3 of the options). |
| 02/24/2027 | Second vesting date for the granted stock options (1/3 of the options). |
| 02/28/2027 | Expiration date of previous option grant. |
| 02/24/2028 | Final vesting date for the granted stock options (1/3 of the options). |
| 03/08/2028 | Expiration date of previous option grant. |
| 03/05/2029 | Expiration date of previous option grant. |
| 02/28/2030 | Expiration date of the granted stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.